Prediction of outcome and selection of the liver transplantat candidate in acute liver failure

Frontiers in Physiology

Volumn 3 AUG, Issue , 2012, Pages

  Hadem, Johannes ^a   Strassburg, Christian P ^b   Manns, Michael P ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Acute hepatitis; Biomarker; Emergency liver transplantation; Hepatic encephalopathy; Hepatic failure; Outcome; Prognosis

Indexed keywords

EID: 84866520840     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2012.00340     Document Type: Review

References (55)

1. Anand, A. C., Nightingale, P., and Neuberger, J. M. (1997). Early indicators of prognosis in fulminant hepatic failure: an assessment of the King's criteria. J. Hepatol. 26, 62-68.
2. Andrade, R. J., Lucena, M. I., Fernández, M. C., Pelaez, G., Pachkoria, K., García-Ruiz, E., García-Muñoz, B., González-Grande, R., Pizarro, A., Durán, J. A., Jiménez, M., Rodrigo, L., Romero-Gomez, M., Navarro, J. M., Planas, R., Costa, J., Borras, A., Soler, A., Salmerón, J., Martin-Vivaldi, R., and Spanish Group for the Study of Drug-Induced Liver Disease. (2005). Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology 129,512-521.
3. Arena, U., Vizzutti, F., Corti, G., Ambu, S., Stasi, C., Bresci, S., Moscarella, S., Boddi, V., Petrarca, A., Laffi, G., Marra, F., and Pinzani, M. (2008). Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology 47, 380-384.
4. Bantel, H., Ruck, P., Gregor, M., and Schulze-Osthoff, K. (2001). Detection of elevated caspase activation and early apoptosis in liver diseases. Eur. J. Cell Biol. 80, 230-239.
5. Bechmann, L. P., Jochum, C., Kocabayoglu, P., Sowa, J. P., Kassalik, M., Gieseler, R. K., Saner, F., Paul, A., Trautwein, C., Gerken, G., and Canbay, A. (2010). Cytokeratin-18 based modification of the MELD score improves prediction of spontaneous survival after acute liver failure. J. Hepatol. 53, 639-647.
6. Beckmann, M. G., Bahr, M. J., Hadem, J., Bredt, M., Wedemeyer, H., Schneider, A. S., Kubicka, S., Manns, M. P., Strassburg, C. P., and Wedemeyer, J. (2009). Clinical relevance of transjugular liver biopsy in comparison with percutaneous and laparoscopic liver biopsy. Gastroenterol. Res. Pract. 2009, 947014.
7. Bernal, W. (2010). Lactate is important in determining prognosis in acute liver failure. J. Hepatol. 53, 209-210.
8. Bernal, W., Auzinger, G., Dhawan, A., and Wendon, J. (2010). Acute liver failure. Lancet 376, 190-201.
9. Bernal, W., Auzinger, and Wendon, J. A. (2009). Prognostic utility of the BiLE score. Clin. Gastroenterol. Hepatol. 7, 249.
10. Bernal, W., Cross, T. J., Auzinger, G., Sizer, E., Heneghan, M. A., Bowles, M., Muiesan, P., Rela, M., Heaton, N., Wendon, J., and O'Grady, J. G. (2009). Outcome after wait-listing for emergency liver transplantation in acute liver failure: a single centre experience.J. Hepatol. 50, 306-313.
11. Bernal, W., Donaldson, N., Wyncoll, D., and Wendon, J. (2002). Blood lac-tate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study. Lancet 359, 558-563.
12. Bernal, W., Hall, C., Karvellas, C. J., Auzinger, G., Sizer, E., and Wendon J. (2007). Arterial ammonia and clinical risk factors for encephalopa-thy and intracranial hypertension in acute liver failure. Hepatology 46, 1844-1852.
13. Bernuau, J., Goudeau, A., Poynard, T., Dubois, F., Lesage, G., Yvonnet, B., Degott, C., Bezeaud, A., Rueff, B., and Benhamou, J. P. (1986). Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology 6, 648-651.
14. Bernuau, J., Nicand, E., and Durand, F. (2008). Hepatitis E-associated acute liver failure in pregnancy: an Indian puzzle. Hepatology 48, 1380-1382.
15. Bismuth, H., Samuel, D., Castaing, D., Adam, R., Saliba, F., Johann, M., Azoulay, D., Ducot, B., and Chiche, L. (1995). Orthotopic liver transplantation in fulminant and subfulminant hepatitis. The Paul Brousse experience. Ann. Surg. 222, 109-119.
16. Bower, W. A., Johns, M., Margolis, H. S., Williams, I. T., and Bell, B. P. (2007). Population-based surveillance for acute liver failure. Am. J. Gastroenterol. 102, 2459-2463.
17. Brown, R. S. (2011). Transplantation for alcoholic hepatitis - time to rethink the 6-month rule. N. Engl. J. Med. 365, 1836-1838.
18. Canbay, A., Jochum, C., Bechmann, L. P., Festag, S., Gieseler, R. K., Yüksel, Z., Lütkes, P., Saner, F. H., Paul, A., and Gerken G. (2009). Acute liver failure in a metropolitan area in Germany: a retrospective study (2002-2008). Z. Gastroenterol. 47, 807-813.
19. Caselitz, M. (1999). "Cirrhosis of the liver," in Ultrasound in Gastroenterology and Hepatology, ed M. Gebel (Berlin: Springer), 40-41.
20. Clemmesen, J. O., Larsen, F. S., Kondrup, J., Hansen, B. A., and Ott, P. (1999). Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. Hepatology 29, 648-653.
21. Craig, D. G., Ford, A. C., Hayes, P. C., and Simpson, K. J. (2010). Systematic review: prognostic tests of paracetamol-induced acute liver failure. Aliment. Pharmacol. Ther. 31, 1064-1076.
22. Craig, D. G., Reid, T. W., Wright, E. C., Martin, K. G., Davidson, J. S., Hayes, P. C., and Simpson, K. J. (2012). The sequential organ failure assessment (SOFA) score is prog-nostically superior to the model for end-stage liver disease (MELD) and MELD variants following paracetamol(acetaminophen) overdose. Aliment. Pharmacol. Ther. 35, 705-713.
23. Dechêne, A., Sowa, J. P., Gieseler, R. K., Jochum, C., Bechmann, L. P., El Fouly, A., Schlattjan, M., Saner, F., Baba, H. A., Paul, A., Dries, V., Odenthal, M., Gerken, G., Friedman, S. L., and Canbay, A. (2010). Acute liver failure is associated with elevated liver stiffness and hepatic stellate cell activation. Hepatology 52, 1008-1016.
24. Escudié, L., Francoz, C., Vinel, J. P., Moucari, R., Cournot, M., Paradis, V., Sauvanet, A., Belghiti, J., Valla, D., Bernuau, J., and Durand, F. (2007). Amanita phalloides poisoning: reassessment of prognostic factors and indications for emergency liver transplantation. J. Hepatol. 46, 466-473.
25. Garcia-Pagán, J. C., Heydtmann, M., Raffa, S., Plessier, A., Murad, S., Fabris, F., Vizzini, G., Abraldes, J. G., Olliff, S., Nicolini, A., Luca, A., Primignani, M., Janssen, H. L., Valla, D., Elias, E., Bosch, J. and Budd-Chiari Syndrome-Transjugular Intrahepatic Portosystemic Shunt Group. (2008).TIPS for Budd-Chiari syndrome: long-term results and prognostic factors in 124 patients. Gastroenterology 135, 808-815.
26. Graham, B. B., Kaul, D. R., Saint, S., and Janssen, W. J. (2009). Kiss of death. N. Engl. J. Med. 360, 2564-2568.
27. Hadem, J., Bockmeyer, C. L., Lukasz, A., Pischke, S., Schneider, A. S., Wedemeyer, H., Jonigk, D., Manns, M. P., and Kümpers, P. (2012). Angiopoietin-2 in acute liver failure. Crit. Care Med. 40, 1499-1505.
28. Hadem, J., Stiefel, P., Bahr, M. J., Tillmann, H. L., Rifai, K., Klempnauer, J., Wedemeyer, H., Manns, M. P., and Schneider, A. S. (2008). Prognostic implications of lactate, bilirubin and etiology in German patients with acute liver failure. Clin. Gastroenterol. Hepatol. 6, 339-345.
29. John, S., and Chung, R. T. (2012). Letter to the editor. N. Engl. J. Med. 366, 477-478
30. Katoonizadeh, A., Decaestecker, J., Wilmer, A., Aerts, R., Verslype, C., Vansteenbergen, W., Yap, P., Fevery, J., Roskams, T., Pirenne, J., and Nevens, F. (2007). MELD score to predict outcome in adult patients with non-acetaminophen-induced acute liver failure. Liver Int. 27, 329-334.
31. Lee, W. M., Stravitz, R. T., and Larson, A. M. (2011). AASLD position paper: the management of acute liver failure: update 2011. Hepatology 55, 965-967.
32. Macquillan, G. C., Seyam, M. S., Nightingale, P., Neuberger, J. M., and Murphy, N. (2005). Blood lactate but not serum phosphate levels can predict patient outcome in fulminant hepatic failure. Liver Transpl. 11, 1073-1079.
33. Mathurin, P., Moreno, C., Samuel, D., Dumortier, J., Salleron, J., Durand, F., Castel, H., Duhamel, A., Pageaux, G. P., Leroy, V., Dharancy, S., Louvet, A., Boleslawski, E., Lucidi, V., Gustot, T., Francoz, C., Letoublon, C., Castaing, D., Belghiti, J., Donckier, V., Pruvot, F. R., and Duclos-Vallée, J. C. (2011). Early liver transplantation for severe alcoholic hepatitis. N. Engl. J. Med. 365, 1790-1800.
34. McPhail, M. J. W., Wendon, J. A., and William, B. (2010). Meta-analysis of performance of Kings's College Hospital Criteria in prediction of outcome in non-paracetamol-induced acute liver failure. J. Hepatol. 53, 492-499.
35. Moreno, C., Duclos-Vallee, J. C., and Mathurin, P. (2012). Author reply. N. Engl. J. Med. 366, 479.
36. Miyake, Y., Sakaguchi, K., Iwasaki, Y., Ikeda, H., Makino, Y., Kobashi, H., Araki, Y., Ando, M., Kita, K., and Shiratori, Y (2005). New prognostic scoring model for liver transplantation in patients with non-acetaminophen-related fulminant hepatic failure. Transplantation 80, 930-936.
37. Murray-Lyon, I. M., Orr, A. H., Gazzard, B., Kohn, J., and Williams, R. (1976). Prognostic value of serum alpha-fetoprotein in fulminant hepatic failure including patients treated by charcoal haemoperfusion. Gut 17, 576-580.
38. Neuberger, J., Gimson, A., Davies, M., Akyol, M., O'Grady, J., Burroughs, A., Hudson, M., and Liver Advisory Group; UK Blood and Transplant. (2008). Selection of patients for liver transplantation and allocation of donated livers in the UK. Gut 57, 252-257.
39. O'Grady, J. G., Alexander, G. J., Hayllar, K. M., and Williams, R. (1989). Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 97, 439-445.
40. Ostapowicz, G., Fontana, R. J., Schiødt, F. V., Larson, A., Davern, T. J., Han, S. H., McCashland, T. M., Shakil, A. O., Hay, J. E., Hynan, L., Crippin, J. S., Blei, A. T., Samuel, G., Reisch, J., Lee, W M., and U.S. Acute Liver Failure Study Group. (2002). Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann. Int. Med. 137, 947-954.
41. Renner, E. L. (2007). How to decide when to list a patient with acute liver failure for liver transplantation? Clichy or King's College criteria, or something else? J. Hepatol. 46, 554-557.
42. Reuben, A., Koch, D. G., Lee, W. M., and Acute Liver Failure Study Group. (2010). Drug-induced acute liver failure: results of a US multicenter, prospective study. Hepatology 52, 2065-2076.
43. Richtlinien Organtransplantation gem. §16 Abs. 1 S. 1 Nrn. 2 und 5 TPG. (2011). Deutsches Ärzteblatt International 12, A662-A673.
44. Sagir, A., Erhardt, A., Schmitt, M., and Häussinger, D. (2008). Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. Hepatology 47, 592-595.
45. Schiødt, F. V., Ostapowicz, G., Murray, N., Satyanarana, R., Zaman, A., Munoz, S., and Lee, W. M. (2006). Alpha-fetoprotein and prognosis in acute liver failure. Liver Transpl. 12, 1776-1781.
46. Schmidt, L. E., and Dalhoff, K. (2002). Serum phosphate is an early predictor of outcome in severe acetaminophen-induced hepatotoxicity. Hepatology 36, 659-665.
47. Schmidt, L. E., and Dalhoff, K. (2005). Alpha-fetoprotein is a predictor of outcome in acetaminophen-induced liver injury. Hepatology 41, 26-31.
48. Schmidt, L. E., and Larsen, F. S. (2006). Prognostic implications of hyperlactatemia, multiple organ failure, and systemic inflammatory response syndrome in patients with acetaminophen-induced acute liver failure. Crit. Care Med. 34, 337-343.
49. Schmidt, L., and Larsen, F. S. (2007). MELD score as a predictor of liver failure and death in patients with acetaminophen-induced liver injury. Hepatology 45, 789-796.
50. Schmidt, L. E., and Larsen, F. S. (2010). Is lactate concentration of major value in determining the prognosis in patients with acute liver failure? Hardly. J. Hepatol. 53, 211-212.
51. Trey, C., and Davidson, C. S. (1970). "The management of fulminant hepatic failure," in Progress in Liver Diseases, eds H. Popper and E Shaffner (New York, NY: Grune and Stratton), 282-298.
52. Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., and Thijs, L. G. (1996). The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the working group on Sepsis-related problems of the European society of intensive care medicine. Intensive Care Med. 22, 707-710.
53. Volkmann, X., Anstaett, M., Hadem, J., Stiefel, P., Bahr, M. J., Lehner, F., Manns, M. P., Schulze-Osthoff, K., and Bantel, H. (2008). Caspase activation is associated with spontaneous recovery from acute liver failure. Hepatology 47, 1624-1633.
54. Westbrook, R. H., Yeoman, A. D., Joshi, D., Heaton, N. D., Quaglia, A., O'Grady, J. G., Auzinger, G., Bernal, W., Heneghan, M. A., and Wendon, J. A. (2010). Outcomes of severe pregnancy-related liver disease: refining the role of transplantation. Am. J. Transplant. 10, 2520-2526.
55. Yantorno, S. E., Kremers, W. K., Ruf, A. E., Trentadue, J. J., Podestá, L. G., and Villamil, E G. (2007). MELD is superior to King's College criteria and Clichy's criteria to assess prognosis in fulminant hepatic failure. Liver Transpl. 13, 822-828.